Similar articles

• T cell adoptive immunotherapy of newly diagnosed gliomas.

  Plautz GE, Miller DW, Barnett GH, Stevens GH, Maffett S, Kim J, Cohen PA, Shu S. Plautz GE, et al. Clin Cancer Res. 2000 Jun;6(6):2209-18. Clin Cancer Res. 2000. PMID: 10873070 Clinical Trial.
• [Immunological study of cerebral tumors in vitro].

  Febvre H, Maunoury R, Constans JP. Febvre H, et al. Neurochirurgie. 1971 May-Jun;17(3):203-7. Neurochirurgie. 1971. PMID: 4330107 French. No abstract available.
• The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

  Papanastassiou V, Rampling R, Fraser M, Petty R, Hadley D, Nicoll J, Harland J, Mabbs R, Brown M. Papanastassiou V, et al. Gene Ther. 2002 Mar;9(6):398-406. doi: 10.1038/sj.gt.3301664. Gene Ther. 2002. PMID: 11960316
• Proceedings: Immunological investigations on human brain tumor patients.

  Mahaley MS Jr. Mahaley MS Jr. Proc Natl Cancer Conf. 1972;7:811-5. Proc Natl Cancer Conf. 1972. PMID: 4358071 Review. No abstract available.
• [Immunology of brain tumors (author's transl)].

  Takakura K. Takakura K. No To Shinkei. 1976 Jun;28(6):525-37. No To Shinkei. 1976. PMID: 194610 Review. Japanese. No abstract available.